The Medicines Co. and generic drug maker Teva Pharmaceutical Industries have reached a settlement that will allow Teva to start selling a generic version of one of MDCO’s drugs by the end of the decade.
Dr. Reddy's Labs has launched a drug for treating Alzheimer's disease, the company said.
Pfizer and Dr. Reddy's have reached a settlement over the latter's efforts to launch a generic version of the world's top-selling drug, according to published reports.
Dr. Reddy’s Labs on Tuesday announced that it has launched its over-the-counter fexofenadine and pseudoephedrine extended-release tablets.
The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating deep vein thrombosis in patients undergoing knee or hip replacement surgery, a J&J subsidiary said.
The Food and Drug Administration has approved a generic anticoagulant drug made by Dr. Reddy’s Labs and Alchemia.
Dr. Reddy’s Labs has launched a generic drug for treating high blood pressure, the company said Thursday.
Generic drug maker Dr. Reddy’s Labs has launched its version of a popular antibiotic.
The Food and Drug Administration has issued a warning letter to Dr. Reddy’s Labs’ chemical manufacturing plant in Mexico, the company said Tuesday.
Dr. Reddy's Labs has received regulatory approval from the Food and Drug Administration for generic versions of treatments for Alzheimer's disease, depression and breast cancer.
A generic drug maker is being sued for patent infringement for its version of a fixed-dose combination drug co-created by Pozen and AstraZeneca.
The Food and Drug Administration has approved Dr. Reddy's version of an allergy medication that recently received Rx-to-OTC switch approval, the generic drug maker said.
Dr. Reddy’s Labs will assume ownership of a penicillin manufacturing site in Bristol, Tenn., from GlaxoSmithKline.
Indian generic drug maker Dr. Reddy’s Labs has launched a generic treatment for seasonal allergies, the company said Tuesday.
A federal court has lifted an injunction that had prevented drug maker Dr. Reddy’s Labs from marketing a generic version of an allergy drug.
Indian drug maker Dr. Reddy’s Labs has launched a generic treatment for gastroesophageal reflux disease.
Indian generic drug maker Dr. Reddy’s Labs has launched a version of an asthma drug...
Dr. Reddy's disclosed on Tuesday it will market a generic peptic ulcer treatment....
Generic drug maker Dr. Reddy’s has launched in India the world’s first follow-on version of...
A U.S. District Court has granted French drug maker Sanofi-Aventis and Albany Molecular Research an...